N(ω)-nitro-L-arginine methyl ester prevents cerebral hyperemia by inhaled anesthetics in dogs

R. W. McPherson, Jeffrey Kirsch, L. E. Moore, R. J. Traystman

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The mechanism by which halothane, isoflurane, and nitrous oxide increase cerebral blood flow (CBF) is unknown. We assessed the cerebrovascular effects of nitrous oxide (70%; n = 6), isoflurane (1 minimum alveolar anesthetic concentration: 1.4%; n = 6) or halothane (1 minimum alveolar anesthetic concentration: 0.8%; n = 6) before and after blockade of nitric oxide (NO) synthase with 40 mg/kg N(ω)-nitro-L-arginine methyl ester (L-NAME) intravenously in dogs with baseline pentobarbital anesthesia. Baseline CBF (microspheres) was determined after 1 h of pentobarbital anesthesia. Cerebral perfusion pressure (CPP) was maintained during inhaled anesthetic or L-NAME by either hemorrhage or inflation of an intra-aortic balloon. Before L-NAME, halothane and isoflurane increased CBF (40 ± 4 to 56 ± 6 mL · min-1 · 100 g-1 and 43 ± 6 to 78 ± 12 mL · min-1 · 100 g-1, respectively) with no change in cerebral oxygen consumption (baseline: halothane, 2.6 ± 0.2; isoflurane, 2.0 ± 0.2 mL · min-1 · 100 g-1). On the contrary, nitrous oxide increased CBF similarly (40 ± 6 to 57 ± 8 mL · min-1 · 100 g-1), but increased cerebral oxygen consumption (2.2 ± 0.3 to 3.0 ± 0.3 mL · min-1 · 100 g-1). L-NAME decreased blood flow in the neurohypophysis by 80% with no change in blood flow in other brain regions. After L-NAME, reexposure to nitrous oxide, halothane, or isoflurane resulted in no change in CBF. These data demonstrate that blockade of NO synthase by L-NAME prevents increased CBF by nitrous oxide, isoflurane, and halothane and suggests that the mechanism of increased CBF with all three anesthetics is mediated via a NO or nitrosothiol mechanism.

Original languageEnglish (US)
Pages (from-to)891-897
Number of pages7
JournalAnesthesia and Analgesia
Volume77
Issue number5
StatePublished - 1993
Externally publishedYes

Fingerprint

Cerebrovascular Circulation
Hyperemia
Anesthetics
Isoflurane
NG-Nitroarginine Methyl Ester
Halothane
Dogs
Nitrous Oxide
Pentobarbital
Oxygen Consumption
Nitric Oxide Synthase
Anesthesia
Posterior Pituitary Gland
arginine methyl ester
Economic Inflation
Microspheres
Nitric Oxide
Hemorrhage

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

N(ω)-nitro-L-arginine methyl ester prevents cerebral hyperemia by inhaled anesthetics in dogs. / McPherson, R. W.; Kirsch, Jeffrey; Moore, L. E.; Traystman, R. J.

In: Anesthesia and Analgesia, Vol. 77, No. 5, 1993, p. 891-897.

Research output: Contribution to journalArticle

McPherson, R. W. ; Kirsch, Jeffrey ; Moore, L. E. ; Traystman, R. J. / N(ω)-nitro-L-arginine methyl ester prevents cerebral hyperemia by inhaled anesthetics in dogs. In: Anesthesia and Analgesia. 1993 ; Vol. 77, No. 5. pp. 891-897.
@article{5185cd0adea54d35a9ae4dce43c6f668,
title = "N(ω)-nitro-L-arginine methyl ester prevents cerebral hyperemia by inhaled anesthetics in dogs",
abstract = "The mechanism by which halothane, isoflurane, and nitrous oxide increase cerebral blood flow (CBF) is unknown. We assessed the cerebrovascular effects of nitrous oxide (70{\%}; n = 6), isoflurane (1 minimum alveolar anesthetic concentration: 1.4{\%}; n = 6) or halothane (1 minimum alveolar anesthetic concentration: 0.8{\%}; n = 6) before and after blockade of nitric oxide (NO) synthase with 40 mg/kg N(ω)-nitro-L-arginine methyl ester (L-NAME) intravenously in dogs with baseline pentobarbital anesthesia. Baseline CBF (microspheres) was determined after 1 h of pentobarbital anesthesia. Cerebral perfusion pressure (CPP) was maintained during inhaled anesthetic or L-NAME by either hemorrhage or inflation of an intra-aortic balloon. Before L-NAME, halothane and isoflurane increased CBF (40 ± 4 to 56 ± 6 mL · min-1 · 100 g-1 and 43 ± 6 to 78 ± 12 mL · min-1 · 100 g-1, respectively) with no change in cerebral oxygen consumption (baseline: halothane, 2.6 ± 0.2; isoflurane, 2.0 ± 0.2 mL · min-1 · 100 g-1). On the contrary, nitrous oxide increased CBF similarly (40 ± 6 to 57 ± 8 mL · min-1 · 100 g-1), but increased cerebral oxygen consumption (2.2 ± 0.3 to 3.0 ± 0.3 mL · min-1 · 100 g-1). L-NAME decreased blood flow in the neurohypophysis by 80{\%} with no change in blood flow in other brain regions. After L-NAME, reexposure to nitrous oxide, halothane, or isoflurane resulted in no change in CBF. These data demonstrate that blockade of NO synthase by L-NAME prevents increased CBF by nitrous oxide, isoflurane, and halothane and suggests that the mechanism of increased CBF with all three anesthetics is mediated via a NO or nitrosothiol mechanism.",
author = "McPherson, {R. W.} and Jeffrey Kirsch and Moore, {L. E.} and Traystman, {R. J.}",
year = "1993",
language = "English (US)",
volume = "77",
pages = "891--897",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - N(ω)-nitro-L-arginine methyl ester prevents cerebral hyperemia by inhaled anesthetics in dogs

AU - McPherson, R. W.

AU - Kirsch, Jeffrey

AU - Moore, L. E.

AU - Traystman, R. J.

PY - 1993

Y1 - 1993

N2 - The mechanism by which halothane, isoflurane, and nitrous oxide increase cerebral blood flow (CBF) is unknown. We assessed the cerebrovascular effects of nitrous oxide (70%; n = 6), isoflurane (1 minimum alveolar anesthetic concentration: 1.4%; n = 6) or halothane (1 minimum alveolar anesthetic concentration: 0.8%; n = 6) before and after blockade of nitric oxide (NO) synthase with 40 mg/kg N(ω)-nitro-L-arginine methyl ester (L-NAME) intravenously in dogs with baseline pentobarbital anesthesia. Baseline CBF (microspheres) was determined after 1 h of pentobarbital anesthesia. Cerebral perfusion pressure (CPP) was maintained during inhaled anesthetic or L-NAME by either hemorrhage or inflation of an intra-aortic balloon. Before L-NAME, halothane and isoflurane increased CBF (40 ± 4 to 56 ± 6 mL · min-1 · 100 g-1 and 43 ± 6 to 78 ± 12 mL · min-1 · 100 g-1, respectively) with no change in cerebral oxygen consumption (baseline: halothane, 2.6 ± 0.2; isoflurane, 2.0 ± 0.2 mL · min-1 · 100 g-1). On the contrary, nitrous oxide increased CBF similarly (40 ± 6 to 57 ± 8 mL · min-1 · 100 g-1), but increased cerebral oxygen consumption (2.2 ± 0.3 to 3.0 ± 0.3 mL · min-1 · 100 g-1). L-NAME decreased blood flow in the neurohypophysis by 80% with no change in blood flow in other brain regions. After L-NAME, reexposure to nitrous oxide, halothane, or isoflurane resulted in no change in CBF. These data demonstrate that blockade of NO synthase by L-NAME prevents increased CBF by nitrous oxide, isoflurane, and halothane and suggests that the mechanism of increased CBF with all three anesthetics is mediated via a NO or nitrosothiol mechanism.

AB - The mechanism by which halothane, isoflurane, and nitrous oxide increase cerebral blood flow (CBF) is unknown. We assessed the cerebrovascular effects of nitrous oxide (70%; n = 6), isoflurane (1 minimum alveolar anesthetic concentration: 1.4%; n = 6) or halothane (1 minimum alveolar anesthetic concentration: 0.8%; n = 6) before and after blockade of nitric oxide (NO) synthase with 40 mg/kg N(ω)-nitro-L-arginine methyl ester (L-NAME) intravenously in dogs with baseline pentobarbital anesthesia. Baseline CBF (microspheres) was determined after 1 h of pentobarbital anesthesia. Cerebral perfusion pressure (CPP) was maintained during inhaled anesthetic or L-NAME by either hemorrhage or inflation of an intra-aortic balloon. Before L-NAME, halothane and isoflurane increased CBF (40 ± 4 to 56 ± 6 mL · min-1 · 100 g-1 and 43 ± 6 to 78 ± 12 mL · min-1 · 100 g-1, respectively) with no change in cerebral oxygen consumption (baseline: halothane, 2.6 ± 0.2; isoflurane, 2.0 ± 0.2 mL · min-1 · 100 g-1). On the contrary, nitrous oxide increased CBF similarly (40 ± 6 to 57 ± 8 mL · min-1 · 100 g-1), but increased cerebral oxygen consumption (2.2 ± 0.3 to 3.0 ± 0.3 mL · min-1 · 100 g-1). L-NAME decreased blood flow in the neurohypophysis by 80% with no change in blood flow in other brain regions. After L-NAME, reexposure to nitrous oxide, halothane, or isoflurane resulted in no change in CBF. These data demonstrate that blockade of NO synthase by L-NAME prevents increased CBF by nitrous oxide, isoflurane, and halothane and suggests that the mechanism of increased CBF with all three anesthetics is mediated via a NO or nitrosothiol mechanism.

UR - http://www.scopus.com/inward/record.url?scp=0027427375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027427375&partnerID=8YFLogxK

M3 - Article

C2 - 8214724

AN - SCOPUS:0027427375

VL - 77

SP - 891

EP - 897

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 5

ER -